MedTrace Logo

Relationship of Ochratoxin A to Upper Urologic Cancers

NCT00216801 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2009-01-21

No results posted yet for this study

Summary

This pilot study will explore the relationship of Ochratoxin A (OTA) levels in patients with upper tract transitional cell (TCC), renal cell, and testicular cancers by measuring levels of OTA in serum and tumor samples. Dietary exposure will also be analyzed.

Conditions

  • Transitional Cell Carcinoma
  • Renal Cell Cancer
  • Testicular Cancer

Sponsors & Collaborators

  • London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

    lead OTHER

Principal Investigators

  • Stephen Pautler, MD, FRCSC · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-09-30
Primary Completion
2007-04-30
Completion
2007-04-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00216801 on ClinicalTrials.gov